UAE-based healthtech company Valeo Health has successfully raised $12 million in its Series B funding round, increasing its total funding to $20 million. This announcement was made in a recent press release, highlighting the company’s strong position in AI-driven healthcare solutions.

The funding round was led by Flintera, with participation from existing investors including Nuwa Capital, FJ Labs, Oryx, and Mindshift Capital. New investors such as Oraseya and Eirad also contributed to this financial boost. The company intends to utilize these funds to enhance its personalized healthcare solutions and expand its presence in Saudi Arabia, the UAE, and the broader GCC region.

Sundeep Sahni, CEO and Co-Founder of Valeo Health, stated that this funding allows the company to scale its AI technology, improve its product offerings, and broaden its reach, ensuring that more individuals have access to proactive healthcare solutions. Additionally, Nitin Reen, a Partner at Nuwa Capital, emphasized that this funding round presents an opportunity to enhance customer centricity and deliver greater value to their stakeholders.